Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Charlotte Graham

Has grant

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Recent Grants

Grant: Close

Mechanisms of cytopenia associated with CAR T cell therapy

Open Date: 2022-09-01

Close Date: 2024-08-31

Articles (17)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (15)

Filippo Birocchi

Harvard University

UNITED STATES

View details

Mohamad Mohty

FRANCE

View details

Jakob R Passweg

Head

University Hospital Basel

SWITZERLAND

View details

Rose-Marie Amini

SWEDEN

View details

Olaf Penack

GERMANY

View details

Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

Charles Crawley

Chair TA Committee B

National Institute for Health and Care Excellence

UNITED KINGDOM

View details

Nicholas Haradhvala

Broad Institute

UNITED STATES

View details

Stephan Mielke

Professor of Hematology and Cell Therapy

Karolinska Institutet

SWEDEN

View details

Zinaida Perić

Associate Professor

University in Rijeka

CROATIA

View details

KRZYSZTOF KALWAK

MD, PhD, Prof.

Wroclaw Medical University

POLAND

View details

Jaime Sanz

Profesor Titular de Universidad

University of Valencia

SPAIN

View details

Tayfun Güngör

University of Zurich

SWITZERLAND

View details

Cristina CASTILLA LLORENTE

Institut Gustave Roussy

FRANCE

View details

Nicolaas Schaap

Radboud University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Charlotte Graham

Research Interests

Explore related searches

Recent Grants

Articles (17)

Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory Diarrhea.

Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study

GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party

The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT.

Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment

IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models.

Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML.

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies

Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party

Management of complications of chimeric antigen receptor T-cell therapy

Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma

Collaborators (15)

Filippo Birocchi

Mohamad Mohty

Jakob R Passweg

Rose-Marie Amini

Olaf Penack

Ibrahim Yakoub-Agha

Charles Crawley

Nicholas Haradhvala

Stephan Mielke

Zinaida Perić

KRZYSZTOF KALWAK

Jaime Sanz

Tayfun Güngör

Cristina CASTILLA LLORENTE

Nicolaas Schaap

Make your next move.